I still own my full position of YBGJ (cost basis a little under 54 cents). Most of my recent attention and money has been focused on trying to establish entries or additional accumulation of other situations/shells. Otherwise that 15 cent ask on YBGJ yesterday would have been extremely tempting to me. I came very close to trying to pick up 10K at that price, but got distracted by other things.
I noticed that YBGJ's unrestricted share count increased by 102K on Friday, so maybe that had some connection to the volume that day.
So far I've handled this stock about as poorly as possible (not securing a nice profit near the top, and not taking the tax loss and buying back in at a lower price), so maybe I will end up regretting not aggressively buying around this 10-25 cent price area. When I was considering taking the tax loss in December, I kept looking at the share structure and valuation and just could not gather the will power to press the sell button.
One thing that has me very puzzled is a company that Yulin Cao (a YBGJ director and basically the scientific brains behind the technology) formed in late August 2021. The company is Beijing Bihe Biotechnology and it has products that are generally/somewhat similar to what YBGJ has. I don't recall what the exact verbiage was, but when the website for that company first started to come online it was noted that YBGJ had some sort of connection with it. But as the website continued to evolve/update, that reference was removed. I'm not sure what is going on there, very confusing/puzzling to me......
Hopefully calendar 2022 will finally have the company/stock make some noticeable progress. The most recent S-1/A filing (February 2022) continues to have the 50 cent fixed price for the proposed insider sales and company financing, so that seems encouraging to me. Also from that same filing, the company continues to believe its employee workforce will triple in 2022.
I think YBGJ posts frequently on its Weixin social media account. It is not always company specific information, but occasionally there can be some interesting things related to the company/products. I don't have a Weixin account, but sometimes the company does put its Weixin posts on its website.
You can find it by using this link below, and click on the item at the bottom of the page.......
If for some reason the above link doesn't function, you can go to the link below, and click on the blue and green image with the red "viv cell" lettering.......
One somewhat interesting item I recall seeing from these Weixin posts around mid-October 2021 was a reference to "Phoenix Club". The link I saved for that post no longer functions. For some reason these Weixin-related links do not always maintain functionality, so if there is some important information in the posts you want to reference later you either have to screenshot it or print it off. Unfortunately I did not save any of the text from that post.
There has not been any mention of "Phoenix Club" in any of YBGJ's filings, nor any mention of it since that Weixin post (I don't monitor YBGJ's website on a daily basis, so it is possible I missed something). As best as I can remember from the post, it appeared as though it is some type of regional centers. Whatever it is, YBGJ seemed to be actively developing it (lining up management/investment) and believed it would be an important part of 2022 for the company.
Everything considered I will probably hang on to my shares, might possibly add to my position, and see how things develop here in 2022. Could end up being another bad decision on my part but at a current valuation of around $25M, I think the potential for some decent upside exists.
News 
Market Data 
Discover 
